Specificity, Inc. SPTY
0.20 USD -0.04 (-16.67%)
At closeNov 4, 2026, 4:00 PM EST
0.1881 Day range 0.20
0.018 52-week range 0.57
- YTD
- +185.71%
- 1 year
- -55.56%
- Market cap
- 3.76M
- EPS (ttm)
- -0.04
- YTD return
- +185.71%
- 1-year return
- -55.56%
- Volume
- 22.10K
- Avg volume
- 52.09K
- Open
- 0.1881
- Previous close
- 0.24
- Day's range
- 0.1881 – 0.20
- 52-week range
- 0.018 – 0.57
1Y -0.1100 (-35.48%)
News
Scribe Therapeutics Reports Preclinical Data at ASGCT 2026 Demonstrating Enhanced Potency and Specificity of Engineered CRISPR Technologies for Epigenetic Silencing and Gene Editing 
Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Detect 
Alamar Biosciences Launches NULISAseq™ Neuro 220 Panel, its largest precision proteomics panel with the sensitivity and specificity to advance neurological disease research 
Alamar Biosciences Launches NULISAseq™ Neuro 220 Panel, its largest precision proteomics panel with the sensitivity and specificity to advance neurological disease research 
Specificity Reports Surge in New Client Partnerships as Strategic Growth Initiatives Begin Delivering Results 
Specificity (OTCID:SPTY) to Present on the Emerging Growth Conference on February 26th, 2026. 
FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test 
Specificity (OTCID: SPTY) Launches Strategic Expansion into $600B Home Services Market with Proprietary Human-Only, Intent-Driven Advertising Platform 
Specificity Founder Jason Wood to Host Live X Spaces Discussion on Market Wire News 
Specificity Announces Partnership with A2SPA to Secure Agentic AI Execution in AdTech
Your note
Sign in to keep a note on SPTY — it syncs with the Stock Master app.